Exscientia
Description
Our internal hit discovery capabilities include biophysical screening methods as well as crystallography and in combination with our state-of-the-art automatic ligand design algorithms, we are able to pursue drug targets that would not be tractable otherwise. Exscientia is at the forefront of Artificial Intelligence (AI) driven drug discovery and the first to design drug molecules entirely by AI...